Clinical Trials Information Network

We stand for a Europe where patients, sites, and sponsors are truly connected, creating faster pathways to innovation and care.

[Clinical Trials Information Network @CTIN_EU]

Today we mark World Kidney Day - a day dedicated to raising awareness about kidney health and the diseases that affect millions of people worldwide. This year, we are especially pleased to collaborate with @KidneyContender

[Kidney Contenders® @KidneyContender]

https://t.co/fnBfLc44dA isn’t just a platform — it’s a bridge. Connecting U.S. decision‑makers to EU trial access. Helping patients find clarity. Supporting researchers with reach. Quiet structure, not loud branding. We see it. We amplify it. #ClinicalTrials #KidneyContenders

[Clinical Trials Information Network @CTIN_EU]

Could iBox transform kidney transplant care?
👉https://t.co/1MW2o1WfGx

@KidneyContender 🧐

#KidneyTransplant #ClinicalResearch #iBox #Transplantation

[Clinical Trials Information Network @CTIN_EU]

@PharmTechGroup Digital adoption and complex molecules are clearly becoming game-changers. Exciting to see how 2026 will push pharma innovation to a whole new level.

[PharmTech Group @PharmTechGroup]

How is pharma innovation evolving? Laine Mello of Ecolab Bioprocessing shares insights on digital adoption in 2025 and the impact of complex molecules shaping 2026. Read more: https://t.co/fdwcl6Zm4y

[Society of Hematologic Oncology (SOHO) @SocietyofHemOnc]

On this https://t.co/b5ANv79J4r podcast, Dr.@TomBmt133 interviews 1st US patient w/ #myeloma who was treated with cilta-cel (then LCAR-B38M) in China. Stay tuned for the full feature 📰 next week.

https://t.co/vwObjAma7O

[Clinical Trials Information Network @CTIN_EU]

@SocietyofHemOnc @TomBmt133 Fascinating insight from the first US patient treated with cilta-cel in China. Can’t wait for the full interview next week!

[Clinical Trials Information Network @CTIN_EU]

@TomBmt133 Absolutely. Real-world data is key to fine-tuning optimal treatment duration. 1300+ Tec patients at ASH will provide invaluable insights to guide everyday clinical decisions.

[Clinical Trials Information Network @CTIN_EU]

@RareRevolutionM Rare ≠ invisible.
This edition shines a light on the undiagnosed community and the teams working worldwide to make every story heard. 🌍✨ #RareAndUndiagnosed

[Clinical Trials Information Network @CTIN_EU]

@Pharmafocus Phase 3 marks a critical step - focusing now on efficacy, safety, and real-world impact. New options in schizophrenia are urgently needed, so this trial is one to watch.

[Clinical Trials Information Network @CTIN_EU]

@ACRPDC In clinical research, compliance and quality aren’t optional. With growing trial complexity, inspection readiness and strong QMS directly impact patient safety and data credibility.

[Clinical Trials Information Network @CTIN_EU]

1 in 7 Indian emerging adults face complex PTSD. Self-organization struggles fuel depression, anxiety & stress. 📊 Read the full study: [https://t.co/CA3EzNuzHO]

[Clinical Trials Information Network @CTIN_EU]

The FDA recently highlighted new developments in food allergy research, noting a surge in clinical trials for novel therapies. These trials are expected to draw significant attention from patients and families seeking more options. #FoodAllergy #FDA @KidneyContender 🍽️🔍

[Clinical Trials Information Network @CTIN_EU]

👋 Hello Poland, hello Spain.

https://t.co/9HO2gSLaCK
https://t.co/Axry9xFpLp

[Clinical Trials Information Network @CTIN_EU]

Democratizing Access to Clinical Trials Across EU Patients: Strengthening Our Liberal Democracy: @lukaszizbicki , CEO, https://t.co/6Uey6WRIV2

[ICT Magazine @IntClinTrials]

ICT Autumn is now live 🍂Take a look inside for discussions on Improving the Patient Experience, Psychoactive Trials and this edition's Alzheimer's Disease and Dementia Focus!
Plus, ICT's Diversity in Pharma Supplement🌈
Read here: https://t.co/KEVYAu0cMM
#pharma #clinicaltrials

[Clinical Trials Information Network @CTIN_EU]

Our mission is to support patients and advocacy groups, especially in rare diseases, as treating these conditions requires better access to clinical trials and tailored information. 🌍 #RareDiseases

[aHUS Alliance Action @aHUSAllianceAct]

Clinical Trials EU: The atypical HUS community has a new way to keep informed about #aHUS #clinicaltrials in Europe. https://t.co/3To5R38ui3 Learn more about the aHUS Alliance Global Action team & a partnership with @CTIN_EU.
#raredisease #CT #complement #TMA #pharma #drug

[Beacon for Rare Diseases @RareBeacon]

Explore the EU Clinical Trials search tool!

Are you interested in discovering more about clinical trials happening across Europe? 🤔

Explore the search tool here for the latest information. 👇

https://t.co/Qx7ZUFNrZ3

[Clinical Trials Information Network @CTIN_EU]

We are excited to announce our partnerships with Huntington's Disease Association and MCT8-Research e.V.

#Huntingtonsdisease #alanherndondudley

[Clinical Trials Information Network @CTIN_EU]

We are excited to announce that our innovative platform: https://t.co/cTRigVTuAG, has been featured in the media! This recognition highlights our commitment to revolutionizing clinical trials in Europe by connecting patients with cutting-edge treatments: https://t.co/Wj0RWbz1Pj